Zobrazeno 1 - 7
of 7
pro vyhledávání: '"M. W. Geerlings"'
Autor:
T K, Nikula, M R, McDevitt, R D, Finn, C, Wu, R W, Kozak, K, Garmestani, M W, Brechbiel, M J, Curcio, C G, Pippin, L, Tiffany-Jones, M W, Geerlings, C, Apostolidis, R, Molinet, O A, Gansow, D A, Scheinberg
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 40(1)
The alpha-particle-emitting radionuclides have several physical characteristics that make them attractive candidates for radioimmunotherapy: (a) high linear energy transfer; (b) short path lengths (50-80 microm); and (c) limited ability of cells to r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a39d6ace035dc0448a7e18301ec6faa
https://pubmed.ncbi.nlm.nih.gov/9935073
https://pubmed.ncbi.nlm.nih.gov/9935073
Autor:
J G, Jurcic, P C, Caron, T K, Nikula, E B, Papadopoulos, R D, Finn, O A, Gansow, W H, Miller, M W, Geerlings, R P, Warrell, S M, Larson
Publikováno v:
Cancer research. 55
M195, a mouse monoclonal antibody reactive with the early myeloid antigen CD33, has been shown to target leukemia cells in patients and to reduce large leukemic burdens when labeled with 131I. A complementarity-determining region-grafted, humanized v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eda92ffd21cf3b7ee884d5a3fbaea78d
https://pubmed.ncbi.nlm.nih.gov/7493368
https://pubmed.ncbi.nlm.nih.gov/7493368
Publikováno v:
Nuclear medicine communications. 16(6)
This paper describes in vitro cytotoxicity experiments with 213Bi- and 225Ac-immunoconjugates on the human epidermoid tumour cell line A431 using a blood group A-reactive murine IgG (2D11) as the specific antibody and MOPC 21 as the control antibody.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d93631c51e57ceaa97fd4ec9b8367bf2
https://pubmed.ncbi.nlm.nih.gov/7675360
https://pubmed.ncbi.nlm.nih.gov/7675360
Publikováno v:
Nuclear medicine communications. 14(2)
This paper proposes the utilization of 225Ac for the alpha-radioimmunotherapy of cancer. The isotope decays with a radioactive half-life of 10 days into a cascade of short-lived alpha- and beta-emitting isotopes. In addition, when indicated by the ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2436c9f791a101fce763664a74bbbad
https://pubmed.ncbi.nlm.nih.gov/8429990
https://pubmed.ncbi.nlm.nih.gov/8429990
Autor:
T. K. Nikula, R. D. Finn, C. Wu, M. Curcio, D. A. Scheinberg, Christos Apostolidis, O. A. Gansow, C. G. Pippin, M. W. Geerlings, R. W. Kozak
Publikováno v:
Journal of Immunotherapy. 16:149
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59f761111defb04d91eb123d44c75951
https://doi.org/10.1097/00002371-199408000-00013
https://doi.org/10.1097/00002371-199408000-00013
Publikováno v:
ract. 10:122-124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::084d8c251734cbc71e31a17cb3082f47
https://doi.org/10.1524/ract.1968.10.34.122
https://doi.org/10.1524/ract.1968.10.34.122
Autor:
L. Koch, M. W. Geerlings
Publikováno v:
ract. 11:49-51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05970e3c32f11b810d8354ec9f08c8b5
https://doi.org/10.1524/ract.1969.11.1.49
https://doi.org/10.1524/ract.1969.11.1.49